A ProspectiveTrial Comparing THUNDERBEAT to the Ligasure Energy Device During Laparoscopic Colon Surgery
Study Details
Study Description
Brief Summary
Prospective randomized controlled study, at Colon and Rectal Surgery, WMC/NYPH. Subjects undergoing Laparoscopic Left Colectomy will be randomized into 1 of 2 groups based on the instrument used for tissue dissection and vessel ligation: Group 1 - THUNDERBEAT Group 2
- Ligasure Population
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Detailed Description
Prospective randomized controlled study, at Colon and Rectal Surgery, WMC/NYPH. Subjects undergoing Laparoscopic Left Colectomy will be randomized into 1 of 2 groups based on the instrument used for tissue dissection and vessel ligation: Group 1 - THUNDERBEAT Group 2
- Ligasure Population: 60 subjects, with colon neoplasm or diverticulitis will be invited in the study after surgery is deemed necessary Study Procedures: This project will consist only of prospective data collection. No interventions will be done for research purpose. Data will be collected prospectively on: -Patients (before, during and after surgery) -The THUNDERBEAT and LigaSure instruments Data will be collected on data collection sheets and entered in a password protected database Primary Outcomes/Definitions- Overall time for dissection of the soft tissues necessary for specimen removal during colon resection, measured in minutes, from the start of colon mobilization to specimen removal from the abdominal cavity.
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Other: THUNDERBEAT THUNDERBEAT energy device ( Olympus) will be used for dissection of tissue and ligation of vessels |
Device: THUNDERBEAT
Tissue dissection and vessels ligation
|
Other: LIGASURE LIGASURE energy device will be used for dissection of tissue and ligation of vessels |
Device: LIGASURE
Tissue dissection and vessels ligation
|
Outcome Measures
Primary Outcome Measures
- Overall Time for Dissection of the Soft Tissues [Day 0 Surgical procedure]
from the start of colon mobilization to specimen removal from the abdominal cavity
- Versatility Score [Day 0 Surgical procedure]
Total/Composite score (composite of 5 variables:hemostasis;sealing;cutting;dissection;and tissue manipulation) was measured by a score system from 1 to 5 (1 being worst and 5 best) for each of the 5 variables,weighted by Coefficient of Importance with weight distribution as follow: hemostasis 0.275, sealing 0.275, cutting 0.2, dissection 0.15, and tissue Manipulation 0.1.). The final reported score is a weighted average.
Secondary Outcome Measures
- Length of Post Surgical Stay in the Hospital [from Surgery date to the discharge date from the hospital up to 30 days]
Length of post surgical stay in the hospital measured in days
- Dryness of the Surgical Field Average Score Mean/sd [Day 0 Surgical Procedure]
Measured by score from 1 to 5 where 1 means Heavy bleeding , hemostasis achieved with the instrument with more than 2 attempts, and 5 means No oozing at vessel or tissue site in entire surgical field .
- Intraoperative Complication Related to the Energy Devices [Day 0 Surgical procedure]
Intraoperative adverse event occurrences during surgery due to the energy devices (THUNDERBEAT and LigaSure) measured as categorical variable "Yes" or "No"
- Delayed Thermal Injuries Related to Energy Devices [DAY 1 to DAY 30 Postsurgery]
Delayed thermal injuries related to Energy devices that occur after surgery within 30 days of the surgical date, measured as categorical variables "Yes" or "No".
- Operative Procedure Time [Day 0 Surgical Procedure]
operative procedure time measured in minutes from the start of the incision to the last stitch in the closure of the surgical incision
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Patients that will be undergoing a Left Laparoscopic Colon Resection
-
Older than 18 years old
-
ASA 1 to 3
-
Elective surgeries
-
Patients who willingly provide informed consent
Exclusion Criteria:
-
Morbidly obese patients (BMI >35)
-
Patients with acute diverticulitis
-
Patients with multiple previous abdominal surgeries
-
Patients on anticoagulants
-
Patients who can not, tolerate a major surgery
-
Patients for whom electrosurgery is contraindicated
-
Patients who are pregnant
-
Patient with IBDs
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Weill Cornell Medical Center- NYPH | New York | New York | United States | 10065 |
Sponsors and Collaborators
- Weill Medical College of Cornell University
- Olympus
Investigators
- Principal Investigator: Jeffrey Milsom, MD, WCMC
Study Documents (Full-Text)
More Information
Publications
None provided.- 1403014955
Study Results
Participant Flow
Recruitment Details | |
---|---|
Pre-assignment Detail | 73 subjects were enrolled, and 60 of them were randomized into the two groups. |
Arm/Group Title | THUNDERBEAT | LIGASURE |
---|---|---|
Arm/Group Description | THUNDERBEAT energy device ( Olympus) will be used for dissection of tissue and ligation of vessels THUNDERBEAT: Tissue dissection and vessels ligation | LIGASURE energy device will be used for dissection of tissue and ligation of vessels LIGASURE: Tissue dissection and vessels ligation |
Period Title: Overall Study | ||
STARTED | 31 | 29 |
COMPLETED | 31 | 29 |
NOT COMPLETED | 0 | 0 |
Baseline Characteristics
Arm/Group Title | THUNDERBEAT | LIGASURE | Total |
---|---|---|---|
Arm/Group Description | THUNDERBEAT energy device ( Olympus) will be used for dissection of tissue and ligation of vessels THUNDERBEAT: Tissue dissection and vessels ligation | LIGASURE energy device will be used for dissection of tissue and ligation of vessels LIGASURE: Tissue dissection and vessels ligation | Total of all reporting groups |
Overall Participants | 31 | 29 | 60 |
Age (years) [Median (Full Range) ] | |||
Median (Full Range) [years] |
54
|
63
|
59.5
|
Sex: Female, Male (Count of Participants) | |||
Female |
14
45.2%
|
17
58.6%
|
31
51.7%
|
Male |
17
54.8%
|
12
41.4%
|
29
48.3%
|
Race and Ethnicity Not Collected (Count of Participants) | |||
Count of Participants [Participants] |
0
0%
|
||
Region of Enrollment (participants) [Number] | |||
United States |
31
100%
|
29
100%
|
60
100%
|
Body mass index(BMI) (kgm^2) [Mean (Standard Deviation) ] | |||
Mean (Standard Deviation) [kgm^2] |
26.3
(4.3)
|
26.4
(4)
|
26.3
(4.2)
|
ASA Class (scores on a scale) [Median (Full Range) ] | |||
Median (Full Range) [scores on a scale] |
2
|
2
|
2
|
Outcome Measures
Title | Overall Time for Dissection of the Soft Tissues |
---|---|
Description | from the start of colon mobilization to specimen removal from the abdominal cavity |
Time Frame | Day 0 Surgical procedure |
Outcome Measure Data
Analysis Population Description |
---|
[Not Specified] |
Arm/Group Title | THUNDERBEAT | LIGASURE |
---|---|---|
Arm/Group Description | THUNDERBEAT energy device ( Olympus) will be used for dissection of tissue and ligation of vessels THUNDERBEAT: Tissue dissection and vessels ligation | LIGASURE energy device will be used for dissection of tissue and ligation of vessels LIGASURE: Tissue dissection and vessels ligation |
Measure Participants | 31 | 29 |
Median (Full Range) [minutes] |
91
|
77
|
Statistical Analysis 1
Statistical Analysis Overview | Comparison Group Selection | THUNDERBEAT, LIGASURE |
---|---|---|
Comments | Because this was a pilot (exploratory) randomized study, no formal sample size calculation was required. Demographic, preoperative, and postoperative variables and the primary outcome were compared between groups (THUNDERBEAT and LigaSure) by the Wilcoxon rank-sum test for continuous variables and the chi-square test/Fisher's exact test for categorical variables, as appropriate. All p-values are two-sided with statistical significance evaluated at the 0.05 alpha level. | |
Type of Statistical Test | Other | |
Comments | Because this was a pilot (exploratory) randomized study, no formal sample size calculation was required. | |
Statistical Test of Hypothesis | p-Value | 0.214 |
Comments | P value threshold <0.05 | |
Method | Wilcoxon (Mann-Whitney) | |
Comments |
Title | Versatility Score |
---|---|
Description | Total/Composite score (composite of 5 variables:hemostasis;sealing;cutting;dissection;and tissue manipulation) was measured by a score system from 1 to 5 (1 being worst and 5 best) for each of the 5 variables,weighted by Coefficient of Importance with weight distribution as follow: hemostasis 0.275, sealing 0.275, cutting 0.2, dissection 0.15, and tissue Manipulation 0.1.). The final reported score is a weighted average. |
Time Frame | Day 0 Surgical procedure |
Outcome Measure Data
Analysis Population Description |
---|
[Not Specified] |
Arm/Group Title | THUNDERBEAT | LIGASURE |
---|---|---|
Arm/Group Description | THUNDERBEAT energy device ( Olympus) will be used for dissection of tissue and ligation of vessels THUNDERBEAT: Tissue dissection and vessels ligation | LIGASURE energy device will be used for dissection of tissue and ligation of vessels LIGASURE: Tissue dissection and vessels ligation |
Measure Participants | 31 | 29 |
Mean (Standard Deviation) [score on a scale] |
4.8
(0.18)
|
4.7
(0.22)
|
Statistical Analysis 1
Statistical Analysis Overview | Comparison Group Selection | THUNDERBEAT, LIGASURE |
---|---|---|
Comments | compared between groups by the Wilcoxon rank-sum test | |
Type of Statistical Test | Other | |
Comments | ||
Statistical Test of Hypothesis | p-Value | 0.007 |
Comments | P value threshold <0.05 | |
Method | Wilcoxon (Mann-Whitney) | |
Comments |
Title | Length of Post Surgical Stay in the Hospital |
---|---|
Description | Length of post surgical stay in the hospital measured in days |
Time Frame | from Surgery date to the discharge date from the hospital up to 30 days |
Outcome Measure Data
Analysis Population Description |
---|
[Not Specified] |
Arm/Group Title | THUNDERBEAT | LIGASURE |
---|---|---|
Arm/Group Description | THUNDERBEAT energy device ( Olympus) will be used for dissection of tissue and ligation of vessels THUNDERBEAT: Tissue dissection and vessels ligation | LIGASURE energy device will be used for dissection of tissue and ligation of vessels LIGASURE: Tissue dissection and vessels ligation |
Measure Participants | 31 | 29 |
Mean (Standard Deviation) [days] |
4.5
(3.1)
|
5.3
(3.9)
|
Title | Dryness of the Surgical Field Average Score Mean/sd |
---|---|
Description | Measured by score from 1 to 5 where 1 means Heavy bleeding , hemostasis achieved with the instrument with more than 2 attempts, and 5 means No oozing at vessel or tissue site in entire surgical field . |
Time Frame | Day 0 Surgical Procedure |
Outcome Measure Data
Analysis Population Description |
---|
[Not Specified] |
Arm/Group Title | THUNDERBEAT | LIGASURE |
---|---|---|
Arm/Group Description | THUNDERBEAT energy device ( Olympus) will be used for dissection of tissue and ligation of vessels THUNDERBEAT: Tissue dissection and vessels ligation | LIGASURE energy device will be used for dissection of tissue and ligation of vessels LIGASURE: Tissue dissection and vessels ligation |
Measure Participants | 31 | 29 |
Mean (Standard Deviation) [score on a scale] |
4.5
(0.38)
|
4.4
(0.33)
|
Title | Intraoperative Complication Related to the Energy Devices |
---|---|
Description | Intraoperative adverse event occurrences during surgery due to the energy devices (THUNDERBEAT and LigaSure) measured as categorical variable "Yes" or "No" |
Time Frame | Day 0 Surgical procedure |
Outcome Measure Data
Analysis Population Description |
---|
[Not Specified] |
Arm/Group Title | THUNDERBEAT | LIGASURE |
---|---|---|
Arm/Group Description | THUNDERBEAT energy device ( Olympus) will be used for dissection of tissue and ligation of vessels THUNDERBEAT: Tissue dissection and vessels ligation | LIGASURE energy device will be used for dissection of tissue and ligation of vessels LIGASURE: Tissue dissection and vessels ligation |
Measure Participants | 31 | 29 |
Number [percentage of total in the group] |
0
|
0
|
Title | Delayed Thermal Injuries Related to Energy Devices |
---|---|
Description | Delayed thermal injuries related to Energy devices that occur after surgery within 30 days of the surgical date, measured as categorical variables "Yes" or "No". |
Time Frame | DAY 1 to DAY 30 Postsurgery |
Outcome Measure Data
Analysis Population Description |
---|
[Not Specified] |
Arm/Group Title | THUNDERBEAT | LIGASURE |
---|---|---|
Arm/Group Description | THUNDERBEAT energy device ( Olympus) will be used for dissection of tissue and ligation of vessels THUNDERBEAT: Tissue dissection and vessels ligation | LIGASURE energy device will be used for dissection of tissue and ligation of vessels LIGASURE: Tissue dissection and vessels ligation |
Measure Participants | 31 | 29 |
Number [percentage of total number in the group] |
0
|
0
|
Statistical Analysis 1
Statistical Analysis Overview | Comparison Group Selection | THUNDERBEAT, LIGASURE |
---|---|---|
Comments | ||
Type of Statistical Test | Other | |
Comments | ||
Statistical Test of Hypothesis | p-Value | 1.0 |
Comments | P value threshold <0.05 | |
Method | Fisher Exact | |
Comments |
Title | Operative Procedure Time |
---|---|
Description | operative procedure time measured in minutes from the start of the incision to the last stitch in the closure of the surgical incision |
Time Frame | Day 0 Surgical Procedure |
Outcome Measure Data
Analysis Population Description |
---|
[Not Specified] |
Arm/Group Title | THUNDERBEAT | LIGASURE |
---|---|---|
Arm/Group Description | THUNDERBEAT energy device ( Olympus) will be used for dissection of tissue and ligation of vessels THUNDERBEAT: Tissue dissection and vessels ligation | LIGASURE energy device will be used for dissection of tissue and ligation of vessels LIGASURE: Tissue dissection and vessels ligation |
Measure Participants | 31 | 29 |
Median (Full Range) [minutes] |
176
|
170
|
Adverse Events
Time Frame | 30 days | |||
---|---|---|---|---|
Adverse Event Reporting Description | Since this is a standard of care procedures no adverse events were recorded. However all intraoperative and postoperative complications were documented as described in the protocol. All the complications that were collected are not qualifying as serous adverse event per protocol. | |||
Arm/Group Title | THUNDERBEAT | LIGASURE | ||
Arm/Group Description | THUNDERBEAT energy device ( Olympus) will be used for dissection of tissue and ligation of vessels THUNDERBEAT: Tissue dissection and vessels ligation | LIGASURE energy device will be used for dissection of tissue and ligation of vessels LIGASURE: Tissue dissection and vessels ligation | ||
All Cause Mortality |
||||
THUNDERBEAT | LIGASURE | |||
Affected / at Risk (%) | # Events | Affected / at Risk (%) | # Events | |
Total | 0/31 (0%) | 0/29 (0%) | ||
Serious Adverse Events |
||||
THUNDERBEAT | LIGASURE | |||
Affected / at Risk (%) | # Events | Affected / at Risk (%) | # Events | |
Total | 0/31 (0%) | 0/29 (0%) | ||
Other (Not Including Serious) Adverse Events |
||||
THUNDERBEAT | LIGASURE | |||
Affected / at Risk (%) | # Events | Affected / at Risk (%) | # Events | |
Total | 3/31 (9.7%) | 9/29 (31%) | ||
Injury, poisoning and procedural complications | ||||
Postoperative Rectal Bleeding | 3/31 (9.7%) | 4/29 (13.8%) | ||
Anastomotic leak | 0/31 (0%) | 2/29 (6.9%) | ||
Wound hematoma incision | 0/31 (0%) | 3/29 (10.3%) |
Limitations/Caveats
More Information
Certain Agreements
All Principal Investigators ARE employed by the organization sponsoring the study.
There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
Results Point of Contact
Name/Title | Koianka Trencheva |
---|---|
Organization | Weill Cornell Medicine |
Phone | 646-9622342 |
kivanova@med.cornell.edu |
- 1403014955